CRP and COVID-19: CRP levels may serve as a useful clinical biomarker for guiding corticosteroid therapy, and in the near future, emerging insights into the immunomodulatory mechanisms of corticosteroids in COVID-19 may help identify corticosteroid-responsive phenotypes.